Q15661 (TRYB1_HUMAN) Homo sapiens (Human)

Tryptase alpha/beta-1 UniProtKBInterProSTRINGInteractive Modelling

275 aa; Sequence (Fasta) ; (Isoform 2); 1 identical sequence: Homo sapiens: P20231

Available Structures

27 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Anti-Tryptase fab E104.v1 bound to tryptase Heteromer
31-274
CA;0GJ;
Assess
Complex between soybean trypsin inhibitor beta1-tryptase and a humanized fab Heteromer
P01070;
31-273
EDO;
Assess
Human beta-1 tryptase mutant Ile99Cyshomo-4-mer31-274
SO4;0GJ;
Assess
HUMAN BETA-TRYPTASE: A RING-LIKE TETRAMER WITH ACTIVE SITES FACING A CENTRAL POREhomo-4-mer31-274
APA;
Assess
Crystal Structure of the Recombinant Human Alpha I Tryptase Mutant K192Q/D216G in Complex with Leup…homo-4-mer31-273
NAG;BU3;NAG;
Assess
Human beta-tryptase co-crystal structure with (6S,8R)-N,N'-bis[3-({4-[3-(aminomethyl)phenyl]piperid…homo-4-mer31-273
MES;SO4;PG4;X2A;
Assess
Human beta-tryptase co-crystal structure with [(1,1,3,3-tetramethyldisiloxane-1,3-diyl)di-1-benzofu…homo-4-mer31-273
CL;PGE;ACT;2AJ;
Assess
Human tryptase with 2-amino benzimidazolehomo-4-mer31-273
270;
Assess
Human beta-tryptase co-crystal structure with [(1,1,3,3-tetramethyldisiloxane-1,3-diyl)di-1-benzoth…homo-4-mer31-273
10×SO4;CL;PGE;2AV;MES;
Assess
beta-tryptase inhibitorhomo-4-mer31-273
P43;
Assess
Potent, Nonpeptide Inhibitors of Human Mast Cell Tryptasehomo-4-mer31-273
11N;
Assess
Crystal Structure of the Recombinant Human Alpha I Tryptase Mutant D216Ghomo-4-mer31-273
NAG;
Assess
human beta-II tryptase in complex with 4-(3-Aminomethyl-phenyl)- piperidin-1-yl-(5-phenethyl- pyrid…homo-4-mer31-273
PM2;
Assess
Human alpha1-tryptasehomo-4-mer31-273
Assess
Human beta-tryptase co-crystal structure with {(1,1,3,3-tetramethyldisiloxane-1,3-diyl)bis[5-(methy…homo-4-mer31-273
10×SO4;PG4;X00;
Assess
human beta-tryptase II complexed with 4-piperidinebutyrate to make acylenzymehomo-4-mer31-273
C1R;
Assess
Human beta tryptase II with inhibitor CRA-28427homo-4-mer31-273
C4A;
Assess
Crystal Structure of the Recombinant Human Alpha I Tryptase Mutant D216G in Complex with Leupeptinhomo-4-mer31-273
NAG;BU3;NAG;
Assess
Crystal Structure of human tryptase with potent non-peptide inhibitorhomo-4-mer31-273
2FF;
Assess
Human beta-tryptase co-crystal structure with (2R,4S)-N,N'-bis[3-({4-[3-(aminomethyl)phenyl]piperid…homo-4-mer31-273
2A4;SO4;MES;CL;
Assess
Human beta II tryptase with inhibitor CRA-27592homo-4-mer31-273
5AM;
Assess
Human beta-tryptase II with inhibitor CRA-29382homo-4-mer31-273
C3A;
Assess
Potent, Nonpeptide Inhibitors of Human Mast Cell Tryptasehomo-4-mer31-273
11M;
Assess
human beta tryptase II complexed with activated ketone inhibitor CRA-29382homo-4-mer31-273
C3A;
Assess
Crystal Structure of Human Beta-Tryptase Complexed with a Synthetic Inhibitor with a Tropanylamide …homo-4-mer31-272
0GX;CO3;
Assess
Human beta-tryptase co-crystal structure with 5-{4-[3-(aminomethyl)phenyl]piperidine-1-carbonyl}-2-…monomer31-273
Y35;SO4;PGE;
Assess
TRYPTASE B2 IN COMPLEX WITH 5-(3-Aminomethyl-phenoxymethyl)-3-[3-(2-chloro-pyridin-3-ylethynyl)-phe…monomer31-272
5TA;
Assess

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
6p0p.1.Amonomer0.9031-273
Y35;99.64
Assess

1 SWISS-MODEL model built on isoform sequence

TemplateIsoformOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 22bm2.1.Ahomo-4-mer0.8631-263
PM2;99.58
Assess